Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ImThera To Debut Neurostim Device For Sleep Apnea In 2010

This article was originally published in The Gray Sheet

Executive Summary

ImThera Medical will begin a clinical trial in November of its Aura6000 neurostimulation implant to treat obstructive sleep apnea, aiming for European marketing approval by the end of 2010

You may also be interested in...



Correction

Obstructive sleep apnea device developer ImThera clarifies that 40% of OSA patients have a moderate to severe form of the condition, and 85% to 90% of OSA is tongue-based (1"The Gray Sheet" Oct. 19, 2009)

COVID-19: ResMed Ramps Up CPAP, BPAP Manufacturing To Address Ventilator Shortage

ResMed plans to double or even triple production of intensive ventilators and sleep apnea machines this year amid rising demand by hospitals to use CPAP and BPAP machines to treat COVID-19 patients during the ventilator shortage. 

Topics

UsernamePublicRestriction

Register

MT028057

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel